Mednax Inc.

19.19+2.18+12.82%Vol 1.29M1Y Perf -28.41%
Jun 5th, 2020 16:00 DELAYED
BID15.00 ASK20.15
Open18.04 Previous Close17.01
Pre-Market- After-Market19.19
 - -%  - -%
Target Price
18.20 
Analyst Rating
Hold 3.10
Potential %
-5.16 
Finscreener Ranking
+     39.83
Insiders Trans % 3/6/12 mo.
-/-/43 
Value Ranking
★+     45.39
Insiders Value % 3/6/12 mo.
-/-/95 
Growth Ranking
+     33.86
Insiders Shares Cnt. % 3/6/12 mo.
-/-/95 
Income Ranking
 —    -
Market Cap1.64B 
Earnings Rating
Strong Sell
Price Range Ratio 52W %
55.52 
Earnings Date
7th May 2020

Today's Price Range

18.0419.86

52W Range

7.3728.66

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
23.57%
1 Month
38.66%
3 Months
19.71%
6 Months
-25.94%
1 Year
-28.41%
3 Years
-65.11%
5 Years
-72.80%
10 Years
-31.48%

TickerPriceChg.Chg.%
MD19.192.180012.82
AAPL331.509.18002.85
GOOG1 438.3926.21001.86
MSFT187.204.28002.34
XOM53.083.98008.11
WFC31.671.45004.80
JNJ147.300.57000.39
FB230.774.48001.98
GE7.880.14001.81
JPM111.234.79004.50
Financial StrengthValueIndustryS&P 500US Markets
2.60
2.70
0.59
1.47
-10.20
Leverage Ratio 2.60
ProfitabilityValueIndustryS&P 500US Markets
24.40
-33.90
-31.70
12.40
-36.30
RevenueValueIndustryS&P 500US Markets
3.51B
41.08
2.04
6.75
Earnings HistoryEstimateReportedSurprise %
Q01 20200.330.25-24.24
Q04 20190.830.863.61
Q03 20190.830.841.20
Q02 20190.780.802.56
Q01 20190.630.58-7.94
Q04 20180.830.841.20
Q03 20180.910.87-4.40
Q02 20181.000.99-1.00
Earnings Per EndEstimateRevision %Trend
6/2020 QR0.44-41.33Negative
9/2020 QR0.70-7.89Negative
12/2020 FY2.03-27.24Negative
12/2021 FY2.71-9.67Negative
Next Report Date-
Estimated EPS Next Report0.48
Estimates Count5
EPS Growth Next 5 Years %10.00
Volume Overview
Volume1.29M
Shares Outstanding85.41M
Trades Count14.70K
Dollar Volume25.94M
Avg. Volume1.40M
Avg. Weekly Volume1.21M
Avg. Monthly Volume1.31M
Avg. Quarterly Volume1.40M

Mednax Inc. (NYSE: MD) stock closed at 19.19 per share at the end of the most recent trading day (a 12.82% change compared to the prior day closing price) with a volume of 1.29M shares and market capitalization of 1.64B. Is a component of Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 11875 people. Mednax Inc. CEO is Roger J. Medel.

The one-year performance of Mednax Inc. stock is -28.41%, while year-to-date (YTD) performance is -30.95%. MD stock has a five-year performance of -72.8%. Its 52-week range is between 7.37 and 28.66, which gives MD stock a 52-week price range ratio of 55.52%

Mednax Inc. currently has a PE ratio of -, a price-to-book (PB) ratio of 0.89, a price-to-sale (PS) ratio of 0.40, a price to cashflow ratio of 5.00, a PEG ratio of 2.32, a ROA of -25.40%, a ROC of -26.90% and a ROE of -59.69%. The company’s profit margin is -36.30%, its EBITDA margin is -31.70%, and its revenue ttm is $3.51 Billion , which makes it $41.08 revenue per share.

Of the last four earnings reports from Mednax Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.48 for the next earnings report. Mednax Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Mednax Inc. is Hold (3.1), with a target price of $18.2, which is -5.16% compared to the current price. The earnings rating for Mednax Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Mednax Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Mednax Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 20.01, ATR14 : 1.16, CCI20 : 210.30, Chaikin Money Flow : 0.17, MACD : 1.08, Money Flow Index : 72.92, ROC : 24.77, RSI : 72.37, STOCH (14,3) : 88.47, STOCH RSI : 1.00, UO : 60.65, Williams %R : -11.53), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Mednax Inc. in the last 12-months were: Dominic J. Andreano (Option Excercise at a value of $0), John C. Pepia (Option Excercise at a value of $0), Michael B. Fernandez (Buy at a value of $8 079 697), Pascal J. Goldschmidt (Sold 10 000 shares of value $218 453 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (10.00 %)
1 (10.00 %)
2 (18.18 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
7 (70.00 %)
7 (70.00 %)
7 (63.64 %)
Moderate Sell
1 (10.00 %)
1 (10.00 %)
1 (9.09 %)
Strong Sell
1 (10.00 %)
1 (10.00 %)
1 (9.09 %)
Summary RatingHold
3.10
Hold
3.10
Hold
2.91

Mednax Inc.

Mednax Inc provides physician services, which include newborn, anesthesia, maternal-fetal, teleradiology, pediatric cardiology, and other pediatric subspecialty care. The firm operates in six segments: neonatal and other pediatric subspecialties, anesthesia, maternal-fetal, pediatric cardiology, radiology, and other services. The neonatal segment contributes the largest proportion of the firm's revenue. Mednax generates virtually all of its revenue in the United States, with over half of its revenue from operations in five states: Texas, North Carolina, Georgia, Tennessee, and Florida. Contracted managed care payors contribute the majority of net collections.

CEO: Roger J. Medel

Teplephone: +1 954 384-0175

Address: 1301 Concord Terrace, Sunrise 33323, FL, USA

Number of employees: 11 875

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

86%14%

Bearish Bullish

92%8%

Bearish Bullish

80%20%

News

Stocktwits